DVA vs ONC
DaVita vs BeOne Medicines AG — AI-powered side-by-side comparison
VS
ONC
BeOne Medicines AG
67
Buy
| Metric | DVA | ONC |
|---|
| AI Score |
53
|
67
|
| Price |
$177.63
|
$376.87
|
| P/E Ratio |
15.18×
|
27.33×
|
| ROE |
-114.7%
|
6.6%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
31.0%
|
87.8%
|
| Debt / Equity |
-14.09×
|
0.22×
|
| Dividend Yield |
0.0%
|
0.0%
|
| RSI (14) |
28.1
|
67.1
|
| Beta |
0.87
|
0.5
|
| Expected Upside |
+1.8%
|
+0.2%
|
AI Committee View
Current Innellis committee reasoning for DVA versus ONC.
ONC leads by 14 points.
ONC scores 67/100 (Buy) versus DVA at 53/100 (Watch).
DVA Committee View
50% agreement
6 analysts
The committee is genuinely divided. Growth Analyst sees a compelling case — 3 consecutive earnings beats -- consistent execution. Risk Analyst remains cautious — high leverage (debt-to-equity 77.99) amplifies downside in a stress scenario. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- P/E of 13.6 is inexpensive for the broad market — Value
- ROE of 181.2% shows genuine earnings power backing the valuation — Value
- 3 consecutive earnings beats -- consistent execution — Growth
Bear Case
- Price-to-book of 101.2x prices in significant intangible value — Value
- Debt-to-equity of 77.99 adds balance-sheet risk to the value case — Value
- RSI at 28 is in oversold territory (could mean either capitulation or a bounce setup) — Technical
ONC Committee View
83% agreement
6 analysts
The committee is genuinely divided. News Analyst sees a compelling case — news sentiment is positive (+1.00 across 1 articles, 14d). Value Analyst remains cautious — p/e of 88.1 is expensive by classic value standards. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- Revenue growing 36.2% YoY -- genuine top-line momentum — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
Bear Case
- P/E of 88.1 is expensive by classic value standards — Value
- Price-to-book of 8.7x prices in significant intangible value — Value
- Price structure (LH_LL) contradicts the uptrend -- mixed signals — Technical